LifeMD, Inc. (LFMD)
3.08
+0.03 (0.98%)
Upcoming Events
Latest Headlines
Form 4 LifeMD, Inc. For: Aug 11 Filed by: LAROVERE JOAN
August 18, 2026 6:12 PM - SEC Filing
Form 4 LifeMD, Inc. For: May 04 Filed by: Strawn John R Jr
August 18, 2026 4:51 PM - SEC Filing
Form 4 LifeMD, Inc. For: Aug 11 Filed by: DiTrolio Joseph
August 13, 2026 9:25 PM - SEC Filing
Form 4/A LifeMD, Inc. For: Dec 02 Filed by: Simon Roberto
August 13, 2026 6:07 PM - SEC Filing
Form 4 LifeMD, Inc. For: May 04 Filed by: Simon Roberto
August 13, 2026 6:03 PM - SEC Filing
Form 4 LifeMD, Inc. For: Aug 11 Filed by: MACRAE CALUM ARCHIBALD
August 13, 2026 5:49 PM - SEC Filing
LifeMD Inc (LFMD) PT Lowered to $8 at B.Riley
August 6, 2026 9:12 AM - StreetInsider
LifeMD Inc (LFMD) PT Lowered to $7 at Mizuho
August 6, 2026 6:52 AM - StreetInsider
UPDATE - LifeMD Reports Second Quarter 2026 Results
August 5, 2026 7:45 PM - Globe NewsWire
LifeMD, Inc. (LFMD) Misses Q2 EPS by 6c
August 5, 2026 5:27 PM - StreetInsider
Form 10-Q LifeMD, Inc. For: Jun 30
August 5, 2026 4:52 PM - SEC Filing
Form 8-K LifeMD, Inc. For: Aug 05
August 5, 2026 4:16 PM - SEC Filing
LifeMD Reports Second Quarter 2026 Results
August 5, 2026 4:12 PM - Globe NewsWire
LifeMD to Report Second Quarter 2026 Financial Results on August 5
July 24, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13G LifeMD, Inc. Filed by: FEDERATED HERMES, INC.
July 8, 2026 7:45 AM - SEC Filing
B.Riley revisits LifeMD Inc (LFMD) following Best Idea designation
June 29, 2026 7:24 AM - StreetInsider
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
June 23, 2026 8:01 AM - Globe NewsWire
Form 8-K LifeMD, Inc. For: Jun 22
June 22, 2026 8:26 AM - SEC Filing
LifeMD to launch self-pay testosterone program with Antares Pharma
June 22, 2026 8:01 AM - StreetInsider
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
June 22, 2026 8:00 AM - Globe NewsWire
Full Article List
